Real-time enrollment status for this immune-mediated hepatitis clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 3:31 AM UTC
| NCT Number | NCT07663422 |
| Recruiting Status | Recruiting |
| Condition | Immune-mediated Hepatitis |
| Phase | PHASE2 |
| Target Enrollment | 31 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Fox Chase Cancer Center |
| Last Updated on CT.gov | September 17, 2026 (Sep 17, 2026) |
As of October 17, 2026: Clinical trial NCT07663422 is currently recruiting participants. This phase2 study for immune-mediated hepatitis is actively seeking new participants at 1 location across the United States. The study is sponsored by Fox Chase Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07663422 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07663422 was last updated Sep 17, 2026 (September 17, 2026). HelloStudys verifies this status automatically.